INTRODUCTION: Liquid nitrogen-based cryoablation induces freezing evenly throughout the probe tip surface, resulting in larger ablation volumes and faster treatment times. The purpose of this preliminary investigation is to determine the efficacy of the liquid nitrogen-based Visica2 Cryoablation System (Sanarus Technologies, Pleasanton, CA) in in vivo porcine kidney, liver, and fibro-fatty tissue. METHODS: Ablations were performed under ultrasound guidance in 4 Yorkshire pigs. The target lesion cross-section width (W) and depth (D) were 1 cm for liver (n=8), kidney (n=4), and head-neck (n=5) and 2 cm for kidney (n=4). Expected axial length (L) of the resulting lesion is approximately 4 cm. After three-day survival, the ablated tissue was harvested and histologically analysed. The mean width and depth were compared with the target diameter using a one-sample t-test. RESULTS: All animals survived the procedure. For the 1 cm target, mean dimensions (L x W x D) were 3.8±1.5 x 1.7±0.3 x 1.7±0.7 for liver, 3.0±0.5 x 2.0±0.4 x 1.7±0.6 for kidney, and 3.3±0.8 x 1.8±0.4 x 1.8±0.4 for head-neck. Mean width and depth were significantly greater than desired dimension. For the 2 cm target, mean dimensions were 3.2±0.5 x 3.1±0.8 x 1.9±0.7. Mean width and depth were not significantly different to desired target. CONCLUSION: Our preliminary results show that the Visica2 liquid nitrogen-based cryoablation system can efficiently and reproducibly create ablation volumes in liver, kidney, and fibro-fatty tissue within 4 minutes and 12 minutes for 1cm and 2cm targeted diameters, respectively. Further investigation is necessary to determine the optimal freeze-thaw-freeze protocol for larger ablation volumes.<br />.
INTRODUCTION: Liquid nitrogen-based cryoablation induces freezing evenly throughout the probe tip surface, resulting in larger ablation volumes and faster treatment times. The purpose of this preliminary investigation is to determine the efficacy of the liquid nitrogen-based Visica2 Cryoablation System (Sanarus Technologies, Pleasanton, CA) in in vivo porcine kidney, liver, and fibro-fatty tissue. METHODS: Ablations were performed under ultrasound guidance in 4 Yorkshire pigs. The target lesion cross-section width (W) and depth (D) were 1 cm for liver (n=8), kidney (n=4), and head-neck (n=5) and 2 cm for kidney (n=4). Expected axial length (L) of the resulting lesion is approximately 4 cm. After three-day survival, the ablated tissue was harvested and histologically analysed. The mean width and depth were compared with the target diameter using a one-sample t-test. RESULTS: All animals survived the procedure. For the 1 cm target, mean dimensions (L x W x D) were 3.8±1.5 x 1.7±0.3 x 1.7±0.7 for liver, 3.0±0.5 x 2.0±0.4 x 1.7±0.6 for kidney, and 3.3±0.8 x 1.8±0.4 x 1.8±0.4 for head-neck. Mean width and depth were significantly greater than desired dimension. For the 2 cm target, mean dimensions were 3.2±0.5 x 3.1±0.8 x 1.9±0.7. Mean width and depth were not significantly different to desired target. CONCLUSION: Our preliminary results show that the Visica2 liquid nitrogen-based cryoablation system can efficiently and reproducibly create ablation volumes in liver, kidney, and fibro-fatty tissue within 4 minutes and 12 minutes for 1cm and 2cm targeted diameters, respectively. Further investigation is necessary to determine the optimal freeze-thaw-freeze protocol for larger ablation volumes.<br />.
Entities:
Keywords:
Cryotherapy; Liver cancer; Minimal invasive surgery; cryoablation; kidney cancer
Authors: Steven P Poplack; Gary M Levine; Lisa Henry; Wendy A Wells; F Scott Heinemann; Cheryl M Hanna; Daniel R Deneen; Tor D Tosteson; Richard J Barth Journal: AJR Am J Roentgenol Date: 2015-05 Impact factor: 3.959
Authors: M Hahn; D Pavlista; J Danes; R Klein; M Golatta; A Harcos; D Wallwiener; I Gruber Journal: Ultraschall Med Date: 2012-11-09 Impact factor: 6.548
Authors: Sonia Gosain; Kim Mercer; William S Twaddell; Lance Uradomo; Bruce D Greenwald Journal: Gastrointest Endosc Date: 2013-04-24 Impact factor: 9.427
Authors: Rache M Simmons; Karla V Ballman; Charles Cox; Ned Carp; Jennifer Sabol; Rosa F Hwang; Deanna Attai; Michael Sabel; David Nathanson; Andrew Kenler; Linsey Gold; Cary Kaufman; Linda Han; Aaron Bleznak; J Stanley Smith; Dennis Holmes; Bruno Fornage; Carisa Le-Petross; Syed Hoda; Linda McCall; Kelly K Hunt Journal: Ann Surg Oncol Date: 2016-05-24 Impact factor: 5.344